Locations:

Tag: breast cancer therapy

Patient with cancer celebrating end of treatment

February 26, 2025/Cancer/News & Insight

When Is De-escalating Systemic Therapy Appropriate in Low-Risk Breast Cancer?

Best practices for reducing toxicities

adverse events from immune checkpoint inhibitors

December 21, 2023/Cancer/News & Insight

Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

March 9, 2023/Cancer/Research

Understanding the Role of Re-irradiation

Fine-tuning radiation for recurrent cancers

January 4, 2023/Cancer/Research

Invasive Lobular Cancer and Invasive Ductal Cancer Require Different Clinical Management

Patients with ER-positive invasive lobular cancer face worse disease-free survival and overall survival

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

November 3, 2022/Cancer/Research

High Rates of Breast Cancer Recurrence after Intraoperative Radiation Therapy

Research supports national guidelines for early-stage breast cancer

June 15, 2022/Cancer/Research

Assessing the Benefit of Endocrine Therapy After Breast-Conserving Surgery in Patients with Ductal Carcinoma In Situ

Multi-center study indicates benefit is associated with risk stratification and the utilization of radiation therapy

September 9, 2021/Cancer/Research

Breast Cancer Survival Hindered By Treatment Delays

Should institutions adopt “time to treatment” as a new quality metric?

BackPage 1 of 1Next